Fundz

NervGen Appoints Sam Jackson as Chief Medical Officer

PUBLIC · NGENNov 18, 2026
New to company · from Aditum Bio“Dr. Jackson most recently served as Chief Medical Officer, Neuroscience at Aditum Bio”

Position

Chief Medical Officer

Company

NERVGEN PHARMA CORP.

Sam Jackson
sjackson@nervgen.com
Other

Description

NervGen has announced the appointment of Sam Jackson, MD, MBA, as Chief Medical Officer. Dr. Jackson brings extensive experience in clinical trial design and execution in neuroscience, which will be pivotal for the company's ongoing studies and clinical strategy.

Quick answer

NervGen Appoints Sam Jackson as Chief Medical Officer (November 18, 2026).

Who is the new Chief Medical Officer at NERVGEN PHARMA CORP?
NERVGEN PHARMA CORP. named Sam Jackson Chief Medical Officer, announced November 18, 2026.
What did NERVGEN PHARMA CORP. announce on November 18, 2026?
NervGen has announced the appointment of Sam Jackson, MD, MBA, as Chief Medical Officer. Dr. Jackson brings extensive experience in clinical trial design and execution in neuroscience, which will be pivotal for the company's ongoing studies and clinical strategy.
Where did Sam Jackson work before joining NERVGEN PHARMA CORP?
Sam Jackson joins from Aditum Bio.
What does NERVGEN PHARMA CORP. do?
NervGen is restoring life's potential by creating innovative solutions for the treatment of nerve damage.

Source: Fundz verified event record.

Who to call at NERVGEN PHARMA CORP., and when

A new leader at NERVGEN PHARMA CORP. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NERVGEN PHARMA CORP. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NERVGEN PHARMA CORP., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NERVGEN PHARMA CORP.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NERVGEN PHARMA CORP.

Location

SUITE 1703 - 595 BURRARD STREET

About

NervGen is restoring life's potential by creating innovative solutions for the treatment of nerve damage.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NERVGEN PHARMA CORP. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sam
Likely contact at this company
••••••••@••••••••

See Sam's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NERVGEN PHARMA CORP.'s next move

Learn about Strategic plan

NERVGEN PHARMA CORP. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.